Yayyy!! Mindbrews First Edition is now live on Magzter!

GlobalLatestNewsPolitics

News Of The Week: Covering India

india china border

Want to know about the core of the latest news of the week? Then you are in the right place. Know about all the nuts and bolts of the trending news of the week in a flow. This blog covers all the top headlines in a concise and visual format along with links and images.

1. LADAKH FACE OFF:

Army patrol teams along the Line of Actual Control with China. Image source: The Hindu

The standoff in Galwan Valley is the result of the claim over the overlapping area between India and China. However, China was responsible for moving in troops and equipment to stop construction activities by India, on the side which was well considered under the Indian Territory.

20 soldiers were martyred

On June 16, Monday, 20 soldiers were martyred in a clash with the Chinese troops in the Galwan area. The violent face-off took place during the de-escalation process in Galwan Valley and resulted in “causalities on both sides”.
However, they reported no firing during the faceoff but iron clubs and rocks were used by the Chinese troops. Three Indian personnel were killed and around 76 personnel were injured.

Suggested:  COVID Positive Ecosystem: Happier and Healthier

Putting his words Prime Minister Narendra Modi promised the nation “The supreme sacrifice of the martyrs would not go in vain.”
Reuters on Thursday reported, satellite images showing the signs of “widening tracks, moving earth and making river crossings”. Also in the evening, China released 10 Indian Soldiers.

No outsiders on Indian Territory, Narendra Modi at the all-party meet:

Prime Minister Narendra Modi said, “no one entered Indian Territory nor were any post taken over.” The emphasis was given on restoring the status quo ante on the borders as reported in a meeting held on Friday.

China lost more than 40 soldiers:

A statement released late Saturday night by Union Minister Gen. V. K. Singh (retd.) said “While India lost 20 soldiers in the violent clash at Galwan area, China lost more than 40 soldiers.”
The armed forces are said to have been given a free hand to access the situation on ground along the Line of Actual Control (LAC) and take appropriate action as required in case of any escalation from the other side, a defense source on Sunday. This was conveyed during a meeting chaired by defense minister Rajnath Singh with the Chief of Defence Staff and the three Service Chiefs.

Suggested:  Meet the next generation of IoT: IIoT 4.0

2. INDIA ELECTED AS NON-PERMANENT MEMBER OF UNITED NATIONS SECURITY COUNCIL:

U.N. diplomats, staff and other personnel arrived at the General Assembly hall wearing masks and immediately left the venue after casting their ballots. Picture courtesy: Twitter/@UN_PGA. Image source: The Hindu

On June 17, India was elected as a non-permanent member of the powerful United Nations Security Council for a two-year term. India won 184 votes in the 193 members’ general assembly. Along with India, Ireland, Mexico and Norway also won the seats.
India will sit in the most powerful United Nations Organisation for a two-year term with overwhelming support from the 5 permanent and 10 non–permanent members.
China, France, Russia, the U.K., and the U.S. are the five permanent members of the UNSC.

Suggested:  Dark Web offering a steady supply of SSL/TLS certificates

3. INDIA’S 1st COVID-19 DRUG FabiFlu launched:

Glenmark has received approval for manufacturing and marketing Favipiravir in oral form in India. Source: The Hindu

Confirmed cases: 436614
Positive cases: 178706
Total Deaths: 13948

Glenmark Pharmaceuticals Ltd. has successfully launched antiviral drug Favipiravir under the brand name FabiFlu in tablet form. FabiFlu is India’s first oral antiviral drug for the treatment of mild and moderate COVID-19 patients.
The cost of the tablets is Rs. 3,500, containing 34 tablets per strip (Rs.103/tablet). It is prescribed to take18 tablets on the first day and 4 tablets from the next day onwards. But the drug will be sold strictly only on prescription.


Meanwhile, drug firm Generic Hetero has received Drug Controller General of India (DCGI) approval to manufacture and sell its generic version of Gilead’s Remdesivir, under the brand name ‘Covifor’. The prices for each 100 mg vial (injectable) is likely to be between Rs. 5000 to Rs.6000. The supplies will begin in a week, as expected.

Pros

Cons

TANYA NAILWAL
About author

Ambitious, Art enthusiast, Novelty seeker, Liberal
Related posts
GlobalHealth & FitnessNews

The new COVID 70% more transmissible: Raise the alarm!!

GlobalLatestPoliticsTechnology

India, Japan enters cyber-security deal on 5G

PoliticsReview

THE MOST SHAMEFUL ASPECT OF INDIA: INCREASING CASES OF RAPE!!

LatestPoliticsReview

#नाथूराम_गोडसे_जिंदाबाद was trending on Twitter, are we taking the freedom for granted?